Your browser doesn't support javascript.
loading
Longitudinal copy number, whole exome and targeted deep sequencing of 'good risk' IGHV-mutated CLL patients with progressive disease.
Rose-Zerilli, M J J; Gibson, J; Wang, J; Tapper, W; Davis, Z; Parker, H; Larrayoz, M; McCarthy, H; Walewska, R; Forster, J; Gardiner, A; Steele, A J; Chelala, C; Ennis, S; Collins, A; Oakes, C C; Oscier, D G; Strefford, J C.
Affiliation
  • Rose-Zerilli MJ; Academic Unit of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Gibson J; Centre for Biological Sciences, Faculty of Natural and Environmental Studies, University of Southampton, Southampton, UK.
  • Wang J; Bioinformatics Unit, Barts Cancer Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Tapper W; Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Davis Z; Department of Haematology, Royal Bournemouth Hospital, Bournemouth, UK.
  • Parker H; Academic Unit of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Larrayoz M; Academic Unit of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
  • McCarthy H; Department of Haematology, Royal Bournemouth Hospital, Bournemouth, UK.
  • Walewska R; Department of Haematology, Royal Bournemouth Hospital, Bournemouth, UK.
  • Forster J; Academic Unit of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Gardiner A; Department of Haematology, Royal Bournemouth Hospital, Bournemouth, UK.
  • Steele AJ; Academic Unit of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Chelala C; Bioinformatics Unit, Barts Cancer Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Ennis S; Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Collins A; Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Oakes CC; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, USA.
  • Oscier DG; Academic Unit of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Strefford JC; Department of Haematology, Royal Bournemouth Hospital, Bournemouth, UK.
Leukemia ; 30(6): 1301-10, 2016 06.
Article in En | MEDLINE | ID: mdl-26847028

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / Immunoglobulin Heavy Chains / Gene Dosage / Exome / Mutation Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Humans / Middle aged Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2016 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / Immunoglobulin Heavy Chains / Gene Dosage / Exome / Mutation Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Humans / Middle aged Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2016 Document type: Article Affiliation country: Country of publication: